Infinity Pharmaceuticals reported $429K in Cost of Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
TG Therapeutics TGTX:US USD 2K 21K
Abbvie ABBV:US USD 5.02B 880M
Amgen AMGN:US USD 1.59B 78M
AstraZeneca AZN:LN USD 2.12B 214M
Bristol Myers Squibb BMY:US USD 2.35B 324M
Eisai 4523:JP JPY 45.13B 2.27B
Eli Lilly And LLY:US USD 1.58B 148.6M
Gilead Sciences GILD:US USD 1.4B 47M
GlaxoSmithKline GSK:LN GBP 2.39B 250M
Infinity Pharmaceuticals INFI:US USD 429K 15K
Johnson & Johnson JNJ:US USD 7.81B 95M
Novartis NOVN:VX USD 3.66B 92M
Pfizer PFE:US USD 6.09B 2.58B
Roche Holding ROG:VX 9.56B 717M
Seattle Genetics SGEN:US USD 108.12M 2.02M
Vascular Biogenics VBLT:US USD 63K 29K
YTE INCY:US USD 49.28M 4.05M